|
Glioblastoma
|
|
|
|
Durmaz R,
Deliorman S, Uyar R, Isiksoy S, Erol K, Tel E
The
effects of anticancer drugs in combination with nimodipine and verapamil on
cultured cells of glioblastoma multiforme
Clin Neurol Neurosurg. 1999 Dec;101(4):238-44
|
|
Huang CX,
Chen B, Zhang YF
Growth
inhibition of epidermal growth factor-stimulated human glioblastoma cells by
nicardipine in vitro
Hunan Yi Ke Da Xue Xue Bao.
2001 Jun 28;26(3):211-4
|
|
|
Gliomas
|
|
|
|
Aas AT,
Brun A, Pero RW, Salford LG.
Chlorpromazine
in combination with nitrosourea inhibits experimental glioma growth.
Br J Neurosurg
1994;8(2):187-92
|
|
Bowles
AP Jr, Pantazis CG, Wansley W
Use of
verapamil to enhance the antiproliferative activity of BCNU in human glioma
cells: an in vitro and in vivo study
J
Neurosurg 1990 Aug;73(2):248-53
|
|
Cloughesy TF, Black
KL, Gobin YP, Farahani K, Nelson G, Villablanca P, Kabbinavar F, Vineula F,
Wortel CH
Intra-arterial
Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent
malignant gliomas
Neurosurgery
1999 Feb;44(2):270-8
|
|
P. Z. New, S. Grossman, T.
Mikkelsen, T. Batchelor, S. Phuphanich, K. Carson, J. Fisher, M. Craig, P.
Cagnoni
Evaluation of safety and tolerance of
escalating doses of RSR13 administered with a fixed dose of BCNU every six weeks
in patients with recurrent malignant glioma: Results of the phase I NABTT 9806
clinical trial
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1533
|
|
Pamela Z New, Stuart A Grossman, Tracy
Batchelor, Fred Hochberg, Surasak Phuphanich, Kathryn Carson, Regina Priett
Evaluation of safety and tolerance of escalating
doses of RSR13 administered with a fixed dose of BCNU every six weeks in
patients with recurrent malignant glioma: preliminary data of NABTT 9806
phase I/II clinical trial
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
2098
|
|
Prados MD, Schold SC JR SC, Fine HA, Jaeckle K, Hochberg F,
Mechtler L, Fetell MR, Phuphanich S, Feun L, Janus TJ, Ford K, Graney W
A
randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in
combination with carboplatin administered intravenously for the treatment
of recurrent malignant glioma
Neuro-oncol. 2003 Apr;5(2):96-103
|
|
Soma MR, Pagliarini P, Butti G, Paoletti R, Paoletti P,
Fumagalli R
Simvastatin, an inhibitor of cholesterol biosynthesis,
shows a synergistic effect with N,N'-bis(2-chloroethyl)-N-nitrosourea and
beta-interferon on human glioma cells
Cancer Res 1992 Aug 15;52(16):4348-55
|
|
|
Metastatic
Tumors
|
|
|
|
Belpomme
D, Gauthier S, Pujade-Lauraine E, Facchini T, Goudier MJ, Krakowski I,
Netter-Pinon G, Frenay M, Gousset C, Marie FN, Benmiloud M, Sturtz F
Verapamil
increases the survival of patients with anthracycline-resistant metastatic
breast carcinoma
Ann Oncol 2000 Nov;11(11):1471-6
|
|
|
Non-Nervous
System Tumors
|
|
|
|
Beiderbeck-Noll
AB, Sturkenboom MC, van der Linden PD, Herings RM, Hofman A, Coebergh JW,
Leufkens HG, Stricker BH
Verapamil
is associated with an increased risk of cancer in the elderly: the Rotterdam
study
Eur J Cancer 2003 Jan;39(1):98-105
|
|
Figueredo A, Arnold A, Goodyear M, Findlay B, Neville A,
Normandeau R, Jones A
Addition
of verapamil and tamoxifen to the initial chemotherapy of small cell lung
cancer. A phase I/II study
Cancer
1990 May 1;65(9):1895-902
|
|
Loo TW,
Clarke DM
Blockage
of drug resistance in vitro by disulfiram, a drug used to treat alcoholism
J Natl Cancer Inst 2000 Jun 7;92(11):898-902
|
|
